A cell simulator platform: The cell collective

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Rather than applying relatively simplistic strategies for direct intervention at intuitively obvious sites, the ability to interrogate biological networks in a systemic context in order to search for nonintuitive approaches cannot be underestimated. Current and future discoveries in quantitative analysis will be difficult or even impossible to apply in the absence of large-scale, accurate models of biochemical/biological systems. We hope that as models in the Cell Collective become more comprehensive, they will provide new opportunities not only to identify and rank individual potential drug targets but also to explore the possibilities of drug repurposing and combinatorial therapies. Rational drug design/discovery is a major problem that has yet to succumb to the power of modern laboratory science. It is likely that more tools will be required to attack this problem, including new ones such as systems and computational approaches. The merging of the laboratory and quantitative analysis has the potential for exciting synergies, and the Cell Collective is designed as a platform on which these synergies can become a reality.

Original languageEnglish (US)
Pages (from-to)393-395
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume93
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Drug Repositioning
Biological Models
Drug Design
Drug Discovery
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

A cell simulator platform : The cell collective. / Helikar, T.; Kowal, B.; Rogers, J. A.

In: Clinical Pharmacology and Therapeutics, Vol. 93, No. 5, 01.05.2013, p. 393-395.

Research output: Contribution to journalArticle

@article{e3020ce7a4d94227b027b8c33ac22740,
title = "A cell simulator platform: The cell collective",
abstract = "Rather than applying relatively simplistic strategies for direct intervention at intuitively obvious sites, the ability to interrogate biological networks in a systemic context in order to search for nonintuitive approaches cannot be underestimated. Current and future discoveries in quantitative analysis will be difficult or even impossible to apply in the absence of large-scale, accurate models of biochemical/biological systems. We hope that as models in the Cell Collective become more comprehensive, they will provide new opportunities not only to identify and rank individual potential drug targets but also to explore the possibilities of drug repurposing and combinatorial therapies. Rational drug design/discovery is a major problem that has yet to succumb to the power of modern laboratory science. It is likely that more tools will be required to attack this problem, including new ones such as systems and computational approaches. The merging of the laboratory and quantitative analysis has the potential for exciting synergies, and the Cell Collective is designed as a platform on which these synergies can become a reality.",
author = "T. Helikar and B. Kowal and Rogers, {J. A.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1038/clpt.2013.41",
language = "English (US)",
volume = "93",
pages = "393--395",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - A cell simulator platform

T2 - The cell collective

AU - Helikar, T.

AU - Kowal, B.

AU - Rogers, J. A.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Rather than applying relatively simplistic strategies for direct intervention at intuitively obvious sites, the ability to interrogate biological networks in a systemic context in order to search for nonintuitive approaches cannot be underestimated. Current and future discoveries in quantitative analysis will be difficult or even impossible to apply in the absence of large-scale, accurate models of biochemical/biological systems. We hope that as models in the Cell Collective become more comprehensive, they will provide new opportunities not only to identify and rank individual potential drug targets but also to explore the possibilities of drug repurposing and combinatorial therapies. Rational drug design/discovery is a major problem that has yet to succumb to the power of modern laboratory science. It is likely that more tools will be required to attack this problem, including new ones such as systems and computational approaches. The merging of the laboratory and quantitative analysis has the potential for exciting synergies, and the Cell Collective is designed as a platform on which these synergies can become a reality.

AB - Rather than applying relatively simplistic strategies for direct intervention at intuitively obvious sites, the ability to interrogate biological networks in a systemic context in order to search for nonintuitive approaches cannot be underestimated. Current and future discoveries in quantitative analysis will be difficult or even impossible to apply in the absence of large-scale, accurate models of biochemical/biological systems. We hope that as models in the Cell Collective become more comprehensive, they will provide new opportunities not only to identify and rank individual potential drug targets but also to explore the possibilities of drug repurposing and combinatorial therapies. Rational drug design/discovery is a major problem that has yet to succumb to the power of modern laboratory science. It is likely that more tools will be required to attack this problem, including new ones such as systems and computational approaches. The merging of the laboratory and quantitative analysis has the potential for exciting synergies, and the Cell Collective is designed as a platform on which these synergies can become a reality.

UR - http://www.scopus.com/inward/record.url?scp=84876664514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876664514&partnerID=8YFLogxK

U2 - 10.1038/clpt.2013.41

DO - 10.1038/clpt.2013.41

M3 - Article

C2 - 23549147

AN - SCOPUS:84876664514

VL - 93

SP - 393

EP - 395

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 5

ER -